Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-08

Clinical Trial Update: Atomized Intranasal Vs Intravenous Ketorolac in Acute Renal Colic Pain Management. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing atomized intranasal ketorolac to intravenous ketorolac for acute renal colic pain, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Oman Medical Speciality Board | Conditions: Acute Renal Colic | Phase 2, Phase 3 | Status: COMPLETED